{
  "retracted": false,
  "timestamp": 1496275200000,
  "updates": [
    {
      "timestamp": 1557351697213,
      "identifier": {
        "doi": "10.1016/j.phrs.2017.04.002"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.phrs.2016.03.021"
  },
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile” [Pharmacol. Res. 110 (August 2016) (2016) 205–215]"
}
